Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Protectan CBLB-502 demonstrates effectiveness in ARS in primates

Aug. 2, 2006

Champix recommended for approval in Europe

July 31, 2006

Suboxone receives approval recommendation in Europe

July 31, 2006

Oral nalmefene demonstrates positive results in pilot smoking cessation study

July 28, 2006

European CHMP hands down positive opinion for Exjade

July 5, 2006

Valera seeks to begin clinical studies of VP-004 naltrexone implant

June 29, 2006

Pfizer patents novel nicotinic acetylcholine receptor modulators for promoting smoking cessation

June 29, 2006

Studies of NRP-104 pharmacokinetics, abuse potential reported

June 29, 2006

Preliminary results from phase II studies of cocaine vaccine TA-CD

June 28, 2006

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

June 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...